Prebiotics, their effect in patients with gastrointestinal diseases.

Background: gastrointestinal diseases GID occur due to morphological and physiological irregularities, affecting the intestinal flora. In the scientific literature, it is reported that, through in vivo and in vitro studies, prebiotics can help improve some of these symptoms, reducing the time of inv...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:: 2022

Institución:: Pontificia Universidad Javeriana Cali

Repositorio:: Vitela

Idioma:: spa

id	Vitela2_26c5b039d480a13a2eaccc222706bab9
oai_identifier_str	oai:vitela.javerianacali.edu.co:11522/456
network_acronym_str	Vitela2
network_name_str	Vitela
repository_id_str
dc.title.en-US.fl_str_mv	Prebiotics, their effect in patients with gastrointestinal diseases.
dc.title.es-ES.fl_str_mv	Prebióticos, su efecto en pacientes con alteraciones gastrointestinales.
title	Prebiotics, their effect in patients with gastrointestinal diseases.
spellingShingle	Prebiotics, their effect in patients with gastrointestinal diseases. Rojas-Renjifo, Katerine Fructooligosacáridos Galactooligosacáridos Inulina Oligofructuosa Oligosacaridos de la leche humana Fructooligosaccharides Galactooligosaccharides Inulin Oligofructose Human milk oligosaccharides
title_short	Prebiotics, their effect in patients with gastrointestinal diseases.
title_full	Prebiotics, their effect in patients with gastrointestinal diseases.
title_fullStr	Prebiotics, their effect in patients with gastrointestinal diseases.
title_full_unstemmed	Prebiotics, their effect in patients with gastrointestinal diseases.
title_sort	Prebiotics, their effect in patients with gastrointestinal diseases.
dc.creator.none.fl_str_mv	Rojas-Renjifo, Katerine Urrego-Restrepo, Lisbeth Melissa Ramírez-Navas, Juan Sebastián
author	Rojas-Renjifo, Katerine
author_facet	Rojas-Renjifo, Katerine Urrego-Restrepo, Lisbeth Melissa Ramírez-Navas, Juan Sebastián
author_role	author
author2	Urrego-Restrepo, Lisbeth Melissa Ramírez-Navas, Juan Sebastián
author2_role	author author
dc.subject.es-ES.fl_str_mv	Fructooligosacáridos Galactooligosacáridos Inulina Oligofructuosa Oligosacaridos de la leche humana
topic	Fructooligosacáridos Galactooligosacáridos Inulina Oligofructuosa Oligosacaridos de la leche humana Fructooligosaccharides Galactooligosaccharides Inulin Oligofructose Human milk oligosaccharides
dc.subject.en-US.fl_str_mv	Fructooligosaccharides Galactooligosaccharides Inulin Oligofructose Human milk oligosaccharides
description	Background: gastrointestinal diseases GID occur due to morphological and physiological irregularities, affecting the intestinal flora. In the scientific literature, it is reported that, through in vivo and in vitro studies, prebiotics can help improve some of these symptoms, reducing the time of involvement and/or avoiding contracting the disease. Aim: The effects of prebiotics in patients suffering from GID, mainly diarrhea, are described through scientific evidence. Materials and methods: A search was carried out in various databases using Boolean operators and the structuring of search equations combining health descriptors. Of the articles identified, those that met the inclusion criteria were selected. Results: The prebiotics FOS, GOS, and FOS/GOS were found to have the best impact on the recovery of patients with GID since they allow better development of the intestinal microbiota and fulfill various functions, for example, the intestinal barrier. Conclusion: The prebiotics, with the most significant scientific evidence reported in the literature, that allow better development of the intestinal microbiota are FOS, GOS, and Inulin. Prebiotics can reduce morbidity and survival of intestinal microbiota after infections of rotavirus, Salmonella, E. coli, and others. However, no specific recommendations were found in the scientific literature for using prebiotics to manage the diarrheal disease.
publishDate	2022
dc.date.accessioned.none.fl_str_mv	2023-10-11T04:34:58Z
dc.date.available.none.fl_str_mv	2023-10-11T04:34:58Z
dc.date.none.fl_str_mv	2022-09-30
dc.type.none.fl_str_mv	info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion
dc.type.es-ES.fl_str_mv	Revisión de la literatura
status_str	publishedVersion
dc.identifier.none.fl_str_mv	https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/650
dc.identifier.uri.none.fl_str_mv	https://vitela.javerianacali.edu.co/handle/11522/456
url	https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/650 https://vitela.javerianacali.edu.co/handle/11522/456
dc.language.none.fl_str_mv	spa
language	spa
dc.relation.none.fl_str_mv	https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/650/553
dc.rights.es-ES.fl_str_mv	Derechos de autor 2023 Salutem Scientia Spiritus https://creativecommons.org/licenses/by-nc-nd/4.0
rights_invalid_str_mv	Derechos de autor 2023 Salutem Scientia Spiritus https://creativecommons.org/licenses/by-nc-nd/4.0
dc.format.none.fl_str_mv	application/pdf
dc.publisher.es-ES.fl_str_mv	Pontificia Universidad Javeriana Cali
dc.source.en-US.fl_str_mv	Salutem Scientia Spiritus; Vol. 8 No. 3 (2022): Revista Salutem Scientia Spiritus; 99-111
dc.source.es-ES.fl_str_mv	Salutem Scientia Spiritus; Vol. 8 Núm. 3 (2022): Revista Salutem Scientia Spiritus; 99-111
dc.source.none.fl_str_mv	2463-1426
institution	Pontificia Universidad Javeriana Cali
repository.name.fl_str_mv	Repositorio Vitela
repository.mail.fl_str_mv	vitela.mail@javerianacali.edu.co
_version_	1812095051528929280
spelling	Rojas-Renjifo, KaterineUrrego-Restrepo, Lisbeth MelissaRamírez-Navas, Juan Sebastián2022-09-302023-10-11T04:34:58Z2023-10-11T04:34:58Zhttps://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/650https://vitela.javerianacali.edu.co/handle/11522/456Background: gastrointestinal diseases GID occur due to morphological and physiological irregularities, affecting the intestinal flora. In the scientific literature, it is reported that, through in vivo and in vitro studies, prebiotics can help improve some of these symptoms, reducing the time of involvement and/or avoiding contracting the disease. Aim: The effects of prebiotics in patients suffering from GID, mainly diarrhea, are described through scientific evidence. Materials and methods: A search was carried out in various databases using Boolean operators and the structuring of search equations combining health descriptors. Of the articles identified, those that met the inclusion criteria were selected. Results: The prebiotics FOS, GOS, and FOS/GOS were found to have the best impact on the recovery of patients with GID since they allow better development of the intestinal microbiota and fulfill various functions, for example, the intestinal barrier. Conclusion: The prebiotics, with the most significant scientific evidence reported in the literature, that allow better development of the intestinal microbiota are FOS, GOS, and Inulin. Prebiotics can reduce morbidity and survival of intestinal microbiota after infections of rotavirus, Salmonella, E. coli, and others. However, no specific recommendations were found in the scientific literature for using prebiotics to manage the diarrheal disease.Introducción: Las alteraciones gastrointestinales AGI se dan por irregularidades morfológicas y fisiológicas, impactando la flora intestinal. En la literatura científica se reporta, que, por medio de estudios in vivo e in vitro, los prebióticos pueden ayudar a mejorar algunas de estas sintomatologías, disminuyendo el tiempo de afectación y/o evitando contraer la enfermedad. Objetivo: Describir los efectos del uso de prebióticos en pacientes que sufren de AGI, principalmente diarrea, a través de evidencia científica. Materiales y métodos: Se realizó una búsqueda en diversas bases de datos empleando operadores boleanos y la estructuración de ecuaciones de búsqueda combinando descriptores en salud. De los artículos identificados, se seleccionaron los que cumplían con los criterios de inclusión. Resultados: Se encontró que los prebióticos con mejores efectos sobre la recuperación de pacientes con AGI son los FOS, GOS y FOS/GOS, dado que permiten un mejor desarrollo de la microbiota intestinal y cumplen con diversas funciones, por ejemplo, de barrera intestinal. Conclusión: Los prebióticos, con mayor evidencia científica reportada en la literatura, que permiten un mejor desarrollo de la microbiota intestinal son FOS, GOS e Inulina. Los prebióticos pueden reducir la morbilidad y la supervivencia de la microbiota intestinal después de infecciones por rotavirus, Salmonella, E. coli, entre otros. Sin embargo, no se encontraron recomendaciones específicas en la literatura científica para el uso de prebióticos para el manejo de la enfermedad diarreica.application/pdfspaPontificia Universidad Javeriana Calihttps://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/650/553Derechos de autor 2023 Salutem Scientia Spiritushttps://creativecommons.org/licenses/by-nc-nd/4.0Salutem Scientia Spiritus; Vol. 8 No. 3 (2022): Revista Salutem Scientia Spiritus; 99-111Salutem Scientia Spiritus; Vol. 8 Núm. 3 (2022): Revista Salutem Scientia Spiritus; 99-1112463-1426FructooligosacáridosGalactooligosacáridosInulinaOligofructuosaOligosacaridos de la leche humanaFructooligosaccharidesGalactooligosaccharidesInulinOligofructoseHuman milk oligosaccharidesPrebiotics, their effect in patients with gastrointestinal diseases.Prebióticos, su efecto en pacientes con alteraciones gastrointestinales.info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisión de la literatura11522/456oai:vitela.javerianacali.edu.co:11522/4562024-06-25 05:12:42.493metadata.onlyhttps://vitela.javerianacali.edu.coRepositorio Vitelavitela.mail@javerianacali.edu.co

Prebiotics, their effect in patients with gastrointestinal diseases.

Publicaciones similares